Press Release Neurimmune sells a portion of its royalty interest in cliramitug to Royalty Pharma Neurimmune · Jul 22
Press Release ADMA Court Alert: ADMA Biologics Investors Seeking to Recover Losses in Securities Fraud Class Action are Notified to Contact BFA Law before August 10 Deadline Bleichmar Fonti & Auld · Jul 22
Press Release EMBC Court Alert: Embecta Investors Seeking to Recover Losses in Securities Fraud Class Action are Notified to Contact BFA Law before August 17 Deadline Bleichmar Fonti & Auld · Jul 22
Press Release NIQ and Circle K Expand Global Analytics Collaboration Across More Than 12 Countries Business Wire · Jul 22
Press Release Observe.AI Announces Strategic Collaboration Agreement with AWS to Accelerate Adoption of AI Agents for Customer Experience Business Wire · Jul 22
Press Release BTU Court Alert: Peabody Investors Seeking to Recover Losses in Securities Fraud Class Action are Notified to Contact BFA Law before August 24 Deadline Bleichmar Fonti & Auld · Jul 22
Press Release Signatera™ MRD Outperformed AMERK Testing in Predicting Merkel Cell Carcinoma Recurrence in JAMA Dermatology Study Business Wire · Jul 22
Press Release LocalImpact Report: 88% of Consumers Have Avoided a Business Due to Negative Reviews Business Wire · Jul 22
Press Release Fishbone Advisors Survey: Institutional Investors See Healthcare’s AI Story as Overblown Business Wire · Jul 22
Press Release Herringbone Names Dan Hinckley Head of AI to Accelerate AI Across Its Platform Business Wire · Jul 22
Press Release Science Corp. Announces European Commercial Launch of PRIMA, the Only Treatment to Restore Functional Central Vision to Patients with Geographic Atrophy Caused by Age-Related Macular Degeneration, a Leading Cause of Blindness Business Wire · Jul 22